While clinical development technologies have come a long way in recent years, research sponsors continue to struggle to connect disparate systems and attain easy access to critical data that will enable better reporting, faster problem solving and increased operational efficiencies. In response, Quanticate, a data-focused global clinical research organization (CRO), chose Comprehend Clinical to integrate into its future research tools as a key part of its strategy to expand its offerings to meet growing sponsor demand for real-time communications and comprehensive clinical data analytics.
“Our selection of Comprehend Systems is a fundamental step in our vision to provide our customers with centralized clinical data services that helps them resolve this data access challenge,” said Daniel Chapple, chief commercial officer at Quanticate.
After Quanticate conducted a thorough evaluation of a range of data analytics vendors, Comprehend Clinical was chosen for its easy-to-use web-based platform and ability to integrate into existing clinical systems. The Quanticate team also valued how the system allows researchers to easily find answers to their problems and dig into key data with no additional programming or complicated spreadsheets.
“During our evaluation process of visualization and analytics software, it became clear that Comprehend Clinical’s competitive advantage is its ability to pull data from any source and deliver it in a way that makes sense to researchers,” said Michael Whitworth, vice president of centralized clinical data sciences at Quanticate. “Comprehend Clinical will enable our sponsors to not only drill down and solve unique, specific problems in real time, but also provide a higher level view of data to tackle broader operational challenges.”
Date: May 3, 2012
Source: Quanticate
Filed Under: Drug Discovery
